Finkelstein CRISP.
Trial name or title | Inhaled steroid adherence in moderate and severe asthma |
Methods | The Internet‐based Home Asthma Telemonitoring (HAT) system, designed to give continuous individualised help to asthma patients following their self‐care plans and to notify their healthcare providers of changes. Patients will take their PEF daily and answer symptom questions on asthma status and an asthma nurse case manager will find out if patients are not following self‐care plans and if there are any clinically significant conditions. She can then contact the patient and give advice about dealing with an exacerbation. |
Participants | 240 inner‐city adult asthma patients for 12 months |
Interventions | Home asthma telehealthcare is designed to provide continuous tailored help to asthma patients |
Outcomes | Clinical outcomes as measured by electronic peak flow, adherence to self‐care |
Starting date | 2005 |
Contact information | Finkelstein |
Notes | — |